DIM — Sartorius Stedim Biotech SA Share News
0.000.00%
- €21.72bn
- €23.90bn
- €2.97bn
Sartorius Q1 misses expectations, shares slump
Brief: Sartorius Q1 Sales Revenue Down By 7.6% In Constant Currencies
Europe Research Roundup: Essilorluxottica, Remy Cointreau, Scout24
Brief: Sartorius Shareholders Approved Proposals Of Executive Board
Europe Research Roundup: Capgemini, Clarkson, Embracer
Brief: Sartorius Supervisory Board Approves 2023 Dividend
Brief: Board Of Directors Of Sartorius Stedim Biotech Propose 0.69 Euros Dividend Per Share
Brief: Sartorius Says Successfully Completes A EUR 1.2 Bln Share Capital Increase Without Shareholders' Preferential Subscription Rights
Brief: Sartorius Says Co Successfully Completes Placement Of 200 Mln Euros Of Treasury Preference Shares
Brief: Sartorius Launches Placement Of Up To Eur 200 Mln Of Treasury Preference Shares Through Accelerated Bookbuilding
Sartorius at 3-week high as it aims for recovery in 2024
Sartorius aims to grow again in 2024 after business slump
Top of the Street: Puma, UniCredit, Sartorius Stedim Biotech
UBS upbeat on European pharma, but flags caution on AstraZeneca
Europe Research Roundup: Adecco Group, Intertek, Sartorius
JPM expects Novo to carry pharma sector in 2024
Europe Research Roundup: Entain, LVMH, Yara International ASA
Refinitiv Newscasts - UK Day Ahead: 10-year gilt prices hit two-month low as US Treasuries fall
Brief: Sartorius 9-Month Operating EBITDA Margin At 28.8%